Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults

Thomas G. Martin, James L. Gajewski

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Acute lymphocytic leukemia remains a difficult disease to treat in adults. Allogeneic bone marrow transplantation can cure some patients with ALL, but GVHD transplant-related mortality and disease relapse remain problematic. Immunotherapeutic approaches aimed at eliminating minimal residual disease and enhancing the GVL effect may decrease relapse rates and improve overall survival. Because of the rarity of this disease in adults, every new patient should be entered in well-designed, peer-reviewed, investigational trial.

Original languageEnglish (US)
Pages (from-to)97-120
Number of pages24
JournalHematology/Oncology Clinics of North America
Issue number1
StatePublished - 2001

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults'. Together they form a unique fingerprint.

Cite this